Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
D008671:Actinoid Series Elements / Q000378:metabolism*; D000818:Animals; D001842:Bone and Bones / Q000378:metabolism; D003238:Connective Tissue / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D008297:Male; D004369:Pentetic Acid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011005:Plutonium / Q000378:metabolism; D011829:Radiation Dosage; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D013997:Time Factors
D008671:Actinoid Series Elements; D011005:Plutonium; D004369:Pentetic Acid